Quarterly report pursuant to Section 13 or 15(d)

Business Acquisitions (Tables)

v3.21.2
Business Acquisitions (Tables)
9 Months Ended
Sep. 30, 2021
Business Acquisition [Line Items]  
Schedule of Intangible Assets Acquisition

The intangible assets preliminarily identified in conjunction with the Nebula Acquisition are as follows (amount in thousands): 

    Gross Carrying Value    

Estimated Useful

Life (in years)

 
Trade names   $ 5,550       15  
Proprietary intellectual property     4,260       5  
Customer relationships     1,180       1  
Total   $ 10,990          

Schedule of Pro-forma Results

The following table summarizes, on a pro forma basis, the combined results of the Company as though the Nebula Acquisition had occurred as of January 1, 2020. These pro forma results are not necessarily indicative of the actual consolidated results had the acquisition occurred as of that date or of the future consolidated operating results for any period. Pro forma results are (in thousands):

 

    September 30, 2021     September 30, 2020     September 30, 2021     September 30, 2020  
    For the three months ended     For the nine months ended  
    September 30, 2021     September 30, 2020     September 30, 2021     September 30, 2020  
Revenue, net   $ 9,843     $ 4,131     $ 36,007     $ 9,890  
Net loss   $ (4,020 )   $ (764 )   $ (4,454 )   $ (2,425 )
Nebula Acquisition [Member]  
Business Acquisition [Line Items]  
Schedule of Assets Acquired and Liabilities Assumed

 

         
Short term investments   $ 1,800  
Accounts receivable     222  
Inventory     435  
Prepaid and other current assets     379  
Definite-lived intangible assets     10,990  
Total assets acquired     13,826  
Accounts payable     (372 )
Accrued expenses and other current liabilities     (43 )
Deferred revenue     (1,140 )
Note payable     (81 )
Total liabilities assumed     (1,636 )
Net identifiable assets acquired     12,190  
Goodwill     484  
Total consideration, net of cash acquired (1)   $ 12,674  

 

(1) Net of $1,639 cash acquired and $257 anticipated amounts due back to the Company from the escrow account.
C P M Acquisition [Member]  
Business Acquisition [Line Items]  
Schedule of Assets Acquired and Liabilities Assumed

 

         
Clinical lab material   $ 180  
Lab equipment     112  
Definite-lived intangible asset     1,307  
Total assets acquired     1,599  
Liabilities assumed     -  
Net identifiable assets acquired     1,599  
Goodwill     901  
Total consideration   $ 2,500